AVITA Medical (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical's Non-Current Debt history runs 3 years deep, the most recent figure standing at $42.2 million for Q2 2025.

• Quarterly Non-Current Debt rose 2.99% year-over-year to $42.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $42.2 million (up 2.99% YoY) and the FY2024 annual result came in at $42.2 million, up 6.11% from the prior year.
• Non-Current Debt was $42.2 million for Q2 2025 at AVITA Medical, up from $41.5 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $42.5 million in Q3 2024 and bottomed at $39.8 million in Q4 2023.
• A 3-year average of $41.5 million and a median of $41.5 million in 2025 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2024 — Non-Current Debt grew 6.11% — and 2025, when it grew 0.39%.
• AVITA Medical's Non-Current Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then slipped by 0.07% to $42.2 million in 2025.
• Business Quant data shows RCEL's Non-Current Debt at $42.2 million in Q2 2025, $41.5 million in Q1 2025, and $42.2 million in Q4 2024.